Free Trial
NASDAQ:VCNX

Vaccinex (VCNX) Stock Price, News & Analysis

Vaccinex logo
$0.75 +0.02 (+2.74%)
As of 07/1/2025 09:30 AM Eastern

About Vaccinex Stock (NASDAQ:VCNX)

Key Stats

Today's Range
$0.75
$0.75
50-Day Range
$0.62
$1.04
52-Week Range
$0.25
$8.90
Volume
117 shs
Average Volume
56,390 shs
Market Capitalization
$1.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VCNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter.

VCNX Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

VCNX Stock Analysis - Frequently Asked Questions

Vaccinex's stock was trading at $0.98 at the beginning of 2025. Since then, VCNX shares have decreased by 23.5% and is now trading at $0.75.
View the best growth stocks for 2025 here
.

Vaccinex, Inc. (NASDAQ:VCNX) released its quarterly earnings data on Monday, November, 8th. The company reported ($35.70) EPS for the quarter, beating the consensus estimate of ($60.90) by $25.20. The business had revenue of $0.05 million for the quarter.

Vaccinex's stock reverse split before market open on Tuesday, February 20th 2024.The 1-14 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Vaccinex (VCNX) raised $45 million in an initial public offering on Thursday, August 9th 2018. The company issued 3,300,000 shares at a price of $12.00-$15.00 per share. Oppenheimer and BTIG acted as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

Shares of VCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaccinex investors own include Pfizer (PFE), VBI Vaccines (VBIV), OPKO Health (OPK), Plug Power (PLUG), Vaxart (VXRT), NIO (NIO) and SNDL (SNDL).

Company Calendar

Last Earnings
11/08/2021
Today
7/01/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VCNX
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.25 million
Pretax Margin
-4,787.89%

Debt

Sales & Book Value

Annual Sales
$388 thousand
Price / Cash Flow
N/A
Book Value
($2.59) per share
Price / Book
-0.29

Miscellaneous

Free Float
1,261,000
Market Cap
$1.95 million
Optionable
No Data
Beta
1.10
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:VCNX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners